Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 02, 2015 9:23 PM ET

Pharmaceuticals

Company Overview of Cephalon, Inc.

Key Executives for Cephalon, Inc.

NameBoard RelationshipsTitleAge
J. Kevin Buchi BE, MBA, CPA76 RelationshipsChief Executive Officer and Director60
Wilco Groenhuysen 12 RelationshipsChief Financial Officer, Principal Accounting Officer and Executive Vice President57
Alain Aragues No RelationshipsExecutive Vice President and President of Cephalon Europe Operations63
Valli F. Baldassano Esq.82 RelationshipsChief Compliance Officer and Executive Vice President54
Lesley Russell Cooper MB. CH.B., MRCP25 RelationshipsChief Medical Officer and Executive Vice President54
View More Key Executives

Cephalon, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
J. Kevin Buchi BE, MBA, CPA 76 RelationshipsTetraLogic Pharmaceuticals Corporation60
Martyn D. Greenacre MBA 29 RelationshipsZynaxis, Inc.73
Dennis L. Winger 49 RelationshipsAccuray Incorporated67
William P. Egan 62 RelationshipsAlta Communications69
Kevin E. Moley 26 RelationshipsAperture Health, Inc68
View All Board Members

Cephalon, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Dennis L. Winger49 Relationships3 Executives
Nominating Committee MBAMartyn D. Greenacre29 Relationships2 Executives
Corporate Governance Committee MBAMartyn D. Greenacre29 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$690.8K
690.8K
456.9K
Bonus
Not meaningful
Total Short Term Compensation$2.6M
2.6M
652.3K
Total Value of Options$690.8K
690.8K
22.5M
Compensation as of Fiscal Year 2010
Cephalon, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

PURE Bioscience, Inc. Announces Executive Changes
July 31, 2015 1:49 PM ET
China Ludao Technology Company Limited Announces Change in Directorships
July 31, 2015 11:46 AM ET
Carewell Industries Limited Announces Management Changes
July 31, 2015 10:03 AM ET
Aunt Fannie's Appoints Mark Haas to Advisory Board
July 31, 2015 8:56 AM ET
The Procter & Gamble Company Announces Executive Changes
July 28, 2015 9:53 AM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cephalon, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.